CARs and cancers: questions and answers

被引：7

作者：

Brentjens, Renier J. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

BLOOD | 2012年 / 119卷 / 17期

关键词：

T-CELLS; PERSISTENCE; LYMPHOMA;

D O I：

10.1182/blood-2012-02-410373

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：3872 / 3873

页数：2

共 10 条

[1]

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias [J].

Brentjens, Renier J. ;

Riviere, Isabelle ;

Park, Jae H. ;

Davila, Marco L. ;

Wang, Xiuyan ;

Stefanski, Jolanta ;

Taylor, Clare ;

Yeh, Raymond ;

Bartido, Shirley ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Bernal, Yvette ;

Pegram, Hollie ;

Przybylowski, Mark ;

Hollyman, Daniel ;

Usachenko, Yelena ;

Pirraglia, Domenick ;

Hosey, James ;

Santos, Elmer ;

Halton, Elizabeth ;

Maslak, Peter ;

Scheinberg, David ;

Jurcic, Joseph ;

Heaney, Mark ;

Heller, Glenn ;

Frattini, Mark ;

Sadelain, Michel .

BLOOD, 2011, 118 (18) :4817-4828

[2]

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens [J].

Dudley, Mark E. ;

Yang, James C. ;

Sherry, Richard ;

Hughes, Marybeth S. ;

Royal, Richard ;

Kammula, Udai ;

Robbins, Paul F. ;

Huang, JianPing ;

Citrin, Deborah E. ;

Leitman, Susan F. ;

Wunderlich, John ;

Restifo, Nicholas P. ;

Thomasian, Armen ;

Downey, Stephanie G. ;

Smith, Franz O. ;

Klapper, Jacob ;

Morton, Kathleen ;

Laurencot, Carolyn ;

White, Donald E. ;

Rosenberg, Steven A. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (32) :5233-5239

[3]

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia [J].

Kalos, Michael ;

Levine, Bruce L. ;

Porter, David L. ;

Katz, Sharyn ;

Grupp, Stephan A. ;

Bagg, Adam ;

June, Carl H. .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (95)

[4]

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells [J].

Kochenderfer, James N. ;

Dudley, Mark E. ;

Feldman, Steven A. ;

Wilson, Wyndham H. ;

Spaner, David E. ;

Maric, Irina ;

Stetler-Stevenson, Maryalice ;

Phan, Giao Q. ;

Hughes, Marybeth S. ;

Sherry, Richard M. ;

Yang, James C. ;

Kammula, Udai S. ;

Devillier, Laura ;

Carpenter, Robert ;

Nathan, Debbie-Ann N. ;

Morgan, Richard A. ;

Laurencot, Carolyn ;

Rosenberg, Steven A. .

BLOOD, 2012, 119 (12) :2709-2720

[5]

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 [J].

Kochenderfer, James N. ;

Wilson, Wyndham H. ;

Janik, John E. ;

Dudley, Mark E. ;

Stetler-Stevenson, Maryalice ;

Feldman, Steven A. ;

Maric, Irina ;

Raffeld, Mark ;

Nathan, Debbie-Ann N. ;

Lanier, Brock J. ;

Morgan, Richard A. ;

Rosenberg, Steven A. .

BLOOD, 2010, 116 (20) :4099-4102

[6]

CARs on Track in the Clinic [J].

Kohn, Donald B. ;

Dotti, Gianpietro ;

Brentjens, Renier ;

Savoldo, Barbara ;

Jensen, Michael ;

Cooper, Laurence J. N. ;

June, Carl H. ;

Rosenberg, Steven ;

Sadelain, Michel ;

Heslop, Helen E. .

MOLECULAR THERAPY, 2011, 19 (03) :432-438

[7]

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2 [J].

Morgan, Richard A. ;

Yang, James C. ;

Kitano, Mio ;

Dudley, Mark E. ;

Laurencot, Carolyn M. ;

Rosenberg, Steven A. .

MOLECULAR THERAPY, 2010, 18 (04) :843-851

[8]

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients [J].

Savoldo, Barbara ;

Ramos, Carlos Almeida ;

Liu, Enli ;

Mims, Martha P. ;

Keating, Michael J. ;

Carrum, George ;

Kamble, Rammurti T. ;

Bollard, Catherine M. ;

Gee, Adrian P. ;

Mei, Zhuyong ;

Liu, Hao ;

Grilley, Bambi ;

Rooney, Cliona M. ;

Heslop, Helen E. ;

Brenner, Malcolm K. ;

Dotti, Gianpietro .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (05) :1822-1826

[9]

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells [J].

Till, Brian G. ;

Jensen, Michael C. ;

Wang, Jinjuan ;

Chen, Eric Y. ;

Wood, Brent L. ;

Greisman, Harvey A. ;

Qian, Xiaojun ;

James, Scott E. ;

Raubitschek, Andrew ;

Forman, Stephen J. ;

Gopal, Ajay K. ;

Pagel, John M. ;

Lindgren, Catherine G. ;

Greenberg, Philip D. ;

Riddell, Stanley R. ;

Press, Oliver W. .

BLOOD, 2008, 112 (06) :2261-2271

[10]

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results [J].

Till, Brian G. ;

Jensen, Michael C. ;

Wang, Jinjuan ;

Qian, Xiaojun ;

Gopal, Ajay K. ;

Maloney, David G. ;

Lindgren, Catherine G. ;

Lin, Yukang ;

Pagel, John M. ;

Budde, Lihua E. ;

Raubitschek, Andrew ;

Forman, Stephen J. ;

Greenberg, Philip D. ;

Riddell, Stanley R. ;

Press, Oliver W. .

BLOOD, 2012, 119 (17) :3940-3950

← 1 →